|
发布时间：2011-05-15 - 点击：14次 - 字数：953字 | Medecins Sans Frontieres (MSF) recently sent a letter to Johnson Johnson criticizing the pharmaceutical company for refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines... |
|
发布时间：2011-05-15 - 点击：13次 - 字数：1441字 | Microbix Biosystems Inc. (TSX: MBX), a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent... |
|
发布时间：2011-04-28 - 点击：3次 - 字数：1778字 | Pro-Pharmaceuticals, Inc. (OTC: PRWP), the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987,... |
|
发布时间：2011-04-26 - 点击：6次 - 字数：1835字 | Cortex Pharmaceuticals, Inc. (OTCBB: CORX) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent that protects its lead AMPAKINE molecule, CX1739. The patent, entitled Di-Substituted Amides for... |
|
发布时间：2011-04-26 - 点击：3次 - 字数：1473字 | NovaSterilis Inc., a leader in the development and commercialization of supercritical carbon dioxide technology, has been granted US Patent 7,919,096. The patent, dated April 5th 2011, is entitled Inactivating Organisms Using... |
|
发布时间：2011-04-23 - 点击：7次 - 字数：2953字 | Florida-based biopharmaceutical company Oragenics, Inc. (OTCBB: ORNI) (www.oragenics.com) announced today the issuance of patent number 7931892 from the United States Patent and Trademark office for ProBiora3 , a proprietary blend of... |
|
发布时间：2011-04-23 - 点击：4次 - 字数：4707字 | A Wayne State University School of Medicine researcher has developed a potential first ever vaccine for Chlamydia, the world's most prevalent sexually transmitted disease and the leading cause of new cases of blindness.... |
|
发布时间：2011-04-23 - 点击：4次 - 字数：886字 | Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market... |
|
发布时间：2011-04-23 - 点击：12次 - 字数：1328字 | POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it and AstraZeneca filed a lawsuit against Dr. Reddy's Laboratories (Dr. Reddy's) in the United States... |
|
发布时间：2011-04-21 - 点击：6次 - 字数：3900字 | Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S. Patent and Trademark Office has issued three patents relating to rifaximin. U.S. Patent No. 7,928,115 (the '115 patent), which issued April 19, 2011,... |
|
发布时间：2011-04-16 - 点击：6次 - 字数：1951字 | Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/010,828 entitled Sustained Release Aminopyridine Composition. The claims... |
|
发布时间：2011-04-15 - 点击：3次 - 字数：1859字 | POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that the U.S. District Court for the Eastern District of Texas has granted a preliminary injunction... |
|
发布时间：2011-04-15 - 点击：4次 - 字数：1926字 | QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary... |
|
发布时间：2011-04-15 - 点击：2次 - 字数：995字 | OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), today announced that the European Patent Office (EPO) has granted European Patent Number EP1545561 entitled Oligonucleotides for Treatment of Prostate and other Cancers. The patent,... |
|
发布时间：2011-04-12 - 点击：3次 - 字数：1914字 | Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery... |
|
|